Cause of Nausea & Vomiting
Radiotherapy & ChemotherapyDuring Pregnancy (Hyperemesis Gravidarum)SurgeryDuring Journey Severe Diarrhea (Acute Gastroenteritis)After Accident
Existing Product Information
Brand Name : PERISET Composition : Ondansetron Hydrochloride USP
8 mg tablet and 4 ml injection (2 mg/ml)
Therapeutic group : Anti-emetic Product group : B & G Pack Size : 3 X 10’s tablets (8 mg tablet)
1 X 5’s ampoules (4 ml injection)
Unit Price (proposed) : 10.00 tk (8 mg tablet) 30.00 tk (4 ml injection)
NEW Product Information
Brand Name : PERISET Composition : Ondansetron Hydrochloride USP
Therapeutic group : Anti-emetic Product group : B & G Pack Size : 1 X 1’s Phial 50 ml Oral Solution (4 mg/ 5 ml) in PET
bottle Unit Price (proposed) : 40.00 tk (50 ml Oral Solution
)
Indications
The management of nausea and vomiting
◙ induced by cytotoxic chemotherapy,
◙ for the prevention and treatment of post-operative nausea and vomiting (PONV)
◙ for the prevention of nausea and vomiting associated with radiotherapy, either total body irradiation or single high dose fraction to the abdomen.
Serotonin release from Small intestine
Vomiting center(medulla)
Serotonin binds with central 5-HT3 receptor inChemoreceptor Trigger zone
Radio & Chemotherapy
Serotonin binds with Serotonin binds with peripheral 5-HT3 receptorperipheral 5-HT3 receptor in GI Tract in GI Tract
VOM reflex
VOM reflex
P
E
R
I
S
E
T
X
X
Mechanism of Action
Ondansetron is a selective Serotonin 5-HT3 receptor antagonist.
Its effects are thought to be on both peripherial and central Vagus nerves. Peripherharal ► reduce the activity of the peripheral vagus nerve, which activates the vomiting center in the medulla oblongata.
Central ► The other is a blockage of serotonin receptors in the chemoreceptor tigger zone.
Dosage And Administration
Age Category Oral Solution
Adults/ Geriatric / Child of 12 years or over
Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Periset Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Periset Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml (8 mg) dose should be administered after 8 hours of the first dose. One 10 ml (8 mg) dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Pediatric (4-11 years) 5 ml (4 mg) Periset Oral Solution should be taken 30 minutes before the start of chemotherapy. The other 2 doses should be taken 4 and 8 hours after the first dose. Then 5 ml (4 mg) oral solution should be administered 3 times a day (every 8 hours) for 1-2 days after completion of chemotherapy.
Chemotherapy Induced Nausea and Vomiting
Age Category Oral Solution
Adults/ Geriatric / Child of 12 years or over
The recommended oral dosage is 10 ml (8 mg) Periset Oral Solution 3 times daily. For total body irradiation, 10 ml (8 mg) Periset Oral Solution should be administered 1-2 hours before each fraction of radiotherapy administered each day. For single high-dose fraction radiotherapy to the abdomen, one 10 ml (8 mg) Periset Oral Solution should be administered 1-2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1-2 days after completion of radiotherapy. For daily fractionated radiotherapy to the abdomen, 10 ml (8 mg) Periset Oral Solution should be administered 1-2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
Radiotherapy induced nausea and Vomiting
Age Category Oral Solution
Adults/ Geriatric / Child of 12 years or over
20 ml (16 mg) Periset Oral Solution 1 hour before induction of anesthesia.
Postoperative Nausea and Vomiting
Pregnancy category B.
Use In Children
This drug Ondansetron IM/IV injection is recommended for child (from 1 month).
Target Doctors
Oncology Surgery practitioners Hospital practitioners General practitioners Gyane practitioners PC doctors Child specialist
Market Information (Generic)
The market size of Ondansetron is 22.38 crore (app.) with Growth 33.08%.
Ref: 2nd Q, 2012
Brand Company Sales value(crore) yearly
Emistat Healthcare 9.90
Zofra SK+F 3.31
Anset Opsonin 3.24
Onaseron Incepta 2.29
Market Information (Oral Solution)
The market size of Ondansetron is 4.34 crore (app.).
Ref: 2nd Q, 2012
Brand Company Sales value(crore) yearly
Zofra SK+F 1.70
Anset Opsonin 1.08
Onaseron Incepta 0.52
Highlighting Points
PERISET…◙ Relives nausea and vomiting effectively & safely in adults and children
◙ Ensures effective control of vomiting in acute gastroenteritis
◙ Is an effective first-line antiemetic for patients undergoing chemotherapy, radiotherapy and surgery
◙ Safe & effective in hyperemesis gravidarum
NVP Don-A Periset
Nausea and vomiting during
pregnancy
Prevention and relief of acute nausea & vomiting, nausea associated with
migraine
Control nausea & vomiting in various condition (Radiotherapy, Chemotherapy, PONV, Acute gateroenterititis,
Hyperemesis gravidarum)
Stomach mortility Safe for child (IM/IV from 1 month and Tablet, Oral solution from 4 years)
PERISET(Ondansetron Hydrochloride USP)
Presented by
Mohammed Moshiur Rahaman
Brand Executive
Brand Management Department
The ACME Laboratories Ltd.